Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11981703 Polynucleotide constructs
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
August 17, 2017
0
Date of Patent
May 14, 2024
0
Patent Application Number
16326542
0
Patent Citations
US Patent 6919437 Synthetic methods and intermediates for triester oligonucleotides
0
US Patent 8476083 Spectro-temporal optical encoding of information using a time-gated fluorescence resonance transfer (FRET)
0
US Patent 8501930 Peptide-based in vivo siRNA delivery system
0
US Patent 8507455 Folate conjugates
0
US Patent 8541569 Phosphoramidites for synthetic RNA in the reverse direction, efficient RNA synthesis and convenient introduction of 3'-end ligands, chromophores and modifications of synthetic RNA
0
US Patent 8691971 Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating RNA interference
0
US Patent 8853132 Directed synthesis of oligophosphoramidate stereoisomers
0
US Patent 8859755 Method for preparing ribonucleoside phosphorothioate
0
US Patent 9714421 Compositions and methods
0
US Patent 9950001 Polynucleotides having bioreversible groups
0
•••
Patent Inventor Names
Curt W. Bradshaw
0
Son Lam
0
Bryan R. Meade
0
Sukumar Sakamuri
0
Laxman Eltepu
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11981703
0
Patent Primary Examiner
Richard A Schnizer
0
CPC Code
C07F 9/2408
0
C12N 15/113
0
C07H 21/00
0
Find more entities like US Patent 11981703 Polynucleotide constructs
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE